title: Treatment of ulcerated necrobiosis lipoidica with intravenous immunoglobulin and methylprednisolone.
abstract: The authors report a female patient with recalcitrant ulcerated necrobiosis lipoidica (NL) that was resistant to numerous systemic agents and who responded to treatment with intravenous immunoglobulin (IVIG), leading to resolution of the ulcerated areas for several months. Subsequent treatment with two further courses of IVIG was less effective, but a course of intravenous methylprednisolone led to regression of the lesions. As well as briefly reviewing the literature on treatments used to treat ulcerated NL, we outline the pathological mechanisms thought to be involved in the condition and how the modes of action of IVIG might explain its apparent efficacy in this case. As far as we are aware, the response of ulcerated NL to IVIG or methylprednisolone has not been reported previously, although other systemic preparations of corticosteroids have been used.
authors.affiliation: Queen's Medical Centre, Nottingham, United Kingdom. jmb@doctors.org.uk
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Batchelor
authors.forename: Pamela M
authors.initials: PM
authors.lastname: Todd
mesh_terms: D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D008775:Methylprednisolone / Q000008:administration & dosage*; D009335:Necrobiosis Lipoidica / Q000188:drug therapy* / Q000473:pathology; D012883:Skin Ulcer / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone